Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

273.80
Delayed Data
As of Feb 05
 +1.35 / +0.50%
Today’s Change
237.50
Today|||52-Week Range
340.34
-12.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
AssetsCash250.0M2.1B1.5B2.1B
 
 
 
 
 
Short Term Investment Cash-89.4M1.9B-597.0M546.0M
 
 
 
 
 
Cash & Short Term Investments251.0M2.1B1.5B2.1B
 
 
 
 
 
 
ReceivablesReceivables2.4B4.0B4.4B2.1B
 
 
 
 
 
 
InventoriesInventories2.1B3.1B2.8B1.3B
 
 
 
 
 
 
Current AssetsOther Current Assets2.2B1.8B1.8B11.2B
 
 
 
 
 
Current Assets6.9B11.0B10.5B16.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.6B2.8B2.9B1.6B
 
 
 
 
 
Depreciation-1.0B------
 
 
Intangible Assets43.7B125.0B124.4B113.4B
 
 
 
 
 
Other Assets43.8B125.4B124.8B124.4B
 
 
 
 
 
Total Assets52.5B139.5B138.4B142.8B
 
 
 
 
 
 
LiabilitiesAccounts Payable644.6M770.3M971.1M565.9M
 
 
 
 
 
Short Term Debt697.4M1.6B1.6B2.0B
 
 
 
 
 
Accrued Expenses2.9B3.6B3.6B2.9B
 
 
 
 
 
Other Current Liabilities3.2B4.6B4.5B5.0B
 
 
 
 
 
Other Liabilities5.0B7.7B7.6B8.1B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt14.8B42.7B41.3B40.6B
 
 
 
 
 
Deferred Taxes-3.0B-15.3B-15.1B-13.9B
 
 
 
 
 
Other Liabilities34.8M226.2M220.2M808.0M
 
 
 
 
 
Total Liabilities24.2B68.1B66.3B65.3B
 
 
 
 
 
 
EquityMinority Interest0.00-300.0K-1.5M-1.4M
 
 
 
 
Preferred Stock0.004.9B4.9B4.9B
 
 
 
 
Common Equity28.3B66.5B67.1B72.5B
 
 
 
 
 
Total Shareholder Equity28.3B71.4B72.1B77.5B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding265.9M392.3M393.1M394.0M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.